Vitamin D Receptor Activation and Photodynamic Priming Enables Durable Low-dose Chemotherapy

Sriram Anbil(Massachusetts General Hospital), Tayyaba Hasan(Harvard University), Imran Rizvi(King George's Medical University), Yan Baglo(University of Maryland, College Park), Michael Pigula(Scripps Institution of Oceanography), Diane M. Simeone(UC San Diego Health System), Srivalleesha Mallidi(Tufts University), Pushpamali De Silva(Massachusetts General Hospital), Mari Mino–Kenudson(Massachusetts General Hospital), Mans Broekgaarden(Inserm), Edward V. Maytin(Cleveland Clinic), Huang‐Chiao Huang(University of Maryland, Baltimore)
Molecular Cancer Therapeutics
March 27, 2020
10.1158/1535-7163.mct-19-0791
Cited by 48

Related Papers

Identification of Pancreatic Cancer Stem Cells
|Cancer Research|2007|3.4k
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
|Clinical Cancer Research|2016|1.2k
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
|Immunity|2016|954
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
|Gut|2019|620
Inorganic nanoparticles for cancer imaging and therapy
|Journal of Controlled Release|2011|599